Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) were first reported only one year after introduction of the penicillinase-resistant antibiotic methicillin into clinical use and have since become an increasing worldwide problem [12] . Initially, MRSA were restricted to hospitals and sites of high antibiotic use, where they accumulated additional resistances and became multiresistant to all commonly used antibiotics. Recently, however, nonmultiresistant MRSA clones with lower oxacillin resistance levels, but apparently higher virulence, have emerged and begun spreading within the community and into hospitals [2, 5, 17, 18] .
Methicillin resistance is based on the acquisition of an additional penicillin-binding protein (PBP), PBP2a, which has a lower affinity for β-lactams than the cells' own PBPs. Staphylococci differ in their ability to accept PBP2a for unknown reasons [13] . The restriction of MRSA to specific genetic backgrounds is also reflected by the observation that MRSA have generally evolved separately and sometimes even repeatedly into only five of the main 11 distinct epidemic susceptible S. aureus lineages [22] . Methicillin resistance thus depends on both the production of PBP2a and on the genetic composition of the core genome. Strainspecific resistance levels are therefore dictated by the host strain's genetic background and can vary extensively from extremely low (<1 μg/ml) to very high (>1000 μg/ml) oxacillin minimum inhibitory concentrations (MICs) [1] .
The mecA gene, coding for PBP2a, is localized on the staphylococcal chromosomal cassette SCCmec, a unique genomic island, which integrates into the staphylococcal genome [8] . The mecA gene and its cognate regulatory elements mecI-mecR1 form the mec complex. In some strains the regulatory genes mecI-mecR1 may be truncated by insertion elements, giving rise to different mec complex loci. The other feature common to all SCCmec elements is the ccr locus, which encodes recombinases responsible for the site-specific integration and excision of SCCmec [9] . While the ccr genes from different SCCmec elements show sequence polymorphisms, the mecA gene is highly conserved. SCCmec elements vary to a great extent in size, due to additional resistance determinants, plasmids, transposons, IS elements, and genes unrelated to resistance. The classification of SCCmec elements is based on the allotype of the mec and ccr complex as well as the presence of selected loci unrelated to methicillin resistance [19] , which has lead to the identification of six major SCCmec types [10, 11, 14] . A new nomenclature has been proposed to accommodate novel and divergent SCCmec types [3] . The older, hospital-associated SCCmec types I, II, and III are generally larger due to the accumulation of unrelated resistance determinants and other extraneous DNA into the SCCmec element. The emerging community MRSA, with smaller SCCmec elements of type IV, V, or VI, are generally only oligoresistant, express lower methicillin resistance, and grow faster, which appears to give them a fitness advantage. Interestingly, the smaller SCCmec types have entered more diverse strain lineages than the larger types [21, 23] , possibly due to increased mobility, or to a lower fitness burden associated with their typically lower/ heterogeneous methicillin resistance.
The convergence of methicillin resistance with virulence is a dangerous development, especially if combined in rapidly growing strains. Examples include the acquisition of the arginine catabolic mobile element (ACME) associated with SCCmec [6] , or the phage transmitted pvl genes [24] that are connected to many community-acquired MRSA (CA-MRSA). A particularly successful clone is strain USA300, which is spreading at a tremendous rate in the United States [15] .
In recent years the prevalence of MRSA in the 920-bed University Hospital in Zurich had remained relatively low at approximately 3-6%. An epidemiological study performed in 2003 showed that about 30% of the MRSA isolates collected had low oxacillin MICs (43% had MIC ≤ 6 μg/ml) [20] . The majority belonged to a local MRSA clone spreading among intravenous drug users in the Zurich area. This particular "drug clone" appeared in 1994 and steadily proliferated, culminating in 2001 and remaining at quite a high level until 2004 when it constituted over 25% of all MRSA isolated [20] . The drug clone carries the novel SCCmec N1 element, containing a mecB complex and the dfrA and fusB1 genes coding for trimethoprim and fusidic acid resistance, respectively. It also contains two almost identical ccrAB4-like complexes that are similar to previously described ccrAB4 complexes, and a core genome belonging to the successful Berlin CC45 clone [7, 20] . The very low level methicillin resistance of the drug clone is paired with extremely rapid growth; therefore, we were concerned that this clone may spread beyond its confined circle and acquire additional resistance determinants or virulence factors over time. To follow its fate 56 consecutive, non-duplicate MRSA isolates collected from 
Materials and methods

Polymerase chain reaction (PCR)
Specific primers were used to amplify pvl (PVL lukS fwd 5′-GTAAAATGTCTGGACATGATCCA-3′, PVL lukF rev 5′-CAACTGTATTGGATAGCAAAAGC-3′), tst (TSST up 5′-CCCTGTTCCCTTATTATCTA-3′, TSST down 5′-TTCCTTCGCTAGTATGTTGG-3′), and arcA (arcA+ 5′-GAGCCAGAAGTACGCGAG-3′, arcA-5′-CACGTAA CTTGCTAGAACGAG-3′).
Susceptibility testing
Resistance levels for ciprofloxacin, chloramphenicol, trimethoprim, gentamicin, tetracycline, rifampin, fusidic acid, and the MLS antibiotics clindamycin and erythromycin were determined by disk diffusion according to CLSI [4] , and oxacillin MICs were obtained by Etest (AB-Biodisk).
SCCmec typing
Isolates were typed according to Oliveira et al. [19] . ccr typing was performed as described previously [7, 20] .
Pulsed-field gel electrophoresis
Strains were genotyped by pulsed-field gel electrophoresis of SmaI-digested chromosomal DNA, following the protocol given in [20] .
Spa typing spa sequence typing was performed using the Ridom StaphType spa-sequencing protocol (http://www.ridom.de/ doc/Ridom_spa_sequencing.pdf) and the Ridom SpaServer to identify repeats and assign spa types (http://spaserver2. ridom.de/index.shtml).
Results and discussion
MRSA isolates were characterised and grouped according to their SCCmec typing profile and their ccr type. Antibiotic resistance levels to ciprofloxacin, chloramphenicol, trimethoprim, gentamicin, tetracycline, rifampin, fusidic acid, and MLS antibiotics were measured and oxacillin MICs were determined. Isolates were also screened for the presence of pvl, tst, and arcA by PCR. Unexpectedly, a rather large proportion of MRSA from the second collection period seemed to be unstable and 12 strains lost the mecA gene during storage at −80°C. Eleven of these strains appeared to have lost their entire SCCmec elements, as they 
SCCmec variants Fig. 1 ), indicating that the majority of the isolates were not closely related and hence loss of mecA was not associated with a specific clonal background(s). Susceptibility profiles of these strains also showed that there was no clear relationship between these strains (Supplementary Table 1 ). These strains were subsequently removed from the study. (Fig. 1) . Generally, they had high oxacillin MICs and were resistant to ciprofloxacin and erythromycin. Five other isolates amplified multiplex PCR profiles identical or similar to that of type II, but were classified as containing variant SCCmecs on the basis of ccr typing. Two of these contained only ccrAB1 and were considerably more multiresistant than the normal SCCmec type II isolates, and one contained the tst gene. The other three had multiple ccr complexes: ZH299 contained both ccrAB2 and ccrAB1, was PCR-positive for pvl, and had no additional antibiotic resistances; ZH293 had ccrAB2 as well as ccrAB4 and carried tst; the third strain (ZH152) contained both ccrAB1 and ccrAB4. (Fig. 1) . The oxacillin MICs in this group of strains ranged from 1 to over 256 μg/ml. Eight out of the 37 type IV MRSA were pvl positive. Two of these isolates also carried an ACME and were closely related to strain USA300 as they had the same SmaI PFGE pattern. A third type IV SCCmec strain with a different PFGE pattern also carried ACME, but was pvl negative. Type IV MRSA generally had few additional resistances to other antibiotics. The most common resistances found, in decreasing order, were erythromycin in 22 (59.4%), tetracycline in 11 (29.7%), ciprofloxacin in 14 (37.8%), and fusidic acid in five (13.5%) strains. Three additional strains had SCCmec type IV multiplex PCR profiles, but were segregated from this group due to their ccr type. One isolate (ZH273) appeared to contain SCCmec type VI on the basis of amplifying a ccrAB4 complex in addition to the mecA and dcs bands, common to both types IV and VI [16] . This strain was significantly more multiresistant than SCCmec type IV strains. Another isolate (ZH305) contained both ccrAB2 and ccrAB4 and was resistant to four of the ten antibiotics tested. The third (ZH298) contained a ccrAB1 complex, had an exceptionally low oxacillin MIC of 0.38 μg/ml, and its only additional resistance was to fusidic acid. Both ZH305 and ZH298 were grouped with the variant SCCmec types.
Drug clones
Twenty one isolates that amplified only the mecA band by SCCmec typing were confirmed by drug clone specific ccrAB PCR [7] to carry the drug clone SCCmec and were shown to produce the characteristic SmaI pattern of the original type clone CH482 by PFGE [7, 20] , which belongs to ST45 and has the spa type t065. All drug clones were also trimethoprim and fusidic acid resistant. All except six were ciprofloxacin resistant. Their oxacillin resistance levels were low, between 1.5 and 6 μg/ml, and none had acquired additional resistances, suggesting that the drug clone maintained all its characteristics and showed no further evolution to multiresistance or higher oxacillin resistance. The number of drug clone MRSA isolates detected was drastically reduced from 17 isolates in 2004 (30.3%) to only four in 2006 (9.3%) (Fig. 1) .
Conclusion
The The drug clone, which was very prominent in 2003, seems to be on the decline and does not seem to have acquired any additional resistances, nor spread into the hospital. As a long-term consequence of the disruption of the drug scene in 1995, the locally restricted drug clone is dying out, or has possibly moved to other locations that are not in the catchment area of the University Hospital. The frequency of drug addicts hospitalized at the University Hospital has also declined in recent years. Ten strains appeared to contain variant SCCmec types. Many of these were similar to defined SCCmecs but appeared to have undergone deletions, rearrangements, or recombinations, leading to losses of ccr loci or to the accumulation of multiple ccr's. Generally, strains carrying these variant SCCmecs were also divergent in their resistance patterns, oxacillin MIC, and bearing mobile virulence factors such as pvl, tst, or arcA, compared to the corresponding SCCmec type they were most similar to. The observation that almost 10% of the analysed MRSA have undergone SCCmec rearrangements suggests that this chromosomal region is very active. PFGE analysis showed significant genetic diversity amongst the isolates with variant SCCmec profiles (Supplementary Fig. 2) , indicating that the recombination events leading to the evolution of new SCCmec structures had not occurred exclusively or preferentially in any specific clonal background.
